Exome sequencing showed that PCa organoids derived from CTC retained molecular diversity consistent with primary tumors, including TMPRSS2-ERG fusion, SPOP mutation, SPINK1 overexpression, and CHD1 loss. This evidence concerns the gene TMPRSS2 and posterior cortical atrophy.